Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For. | Eur Urol Focus;8(3): 637-638, 2022 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Genomic Sequencing Should Be Part of the Standard of Care for Most Urologic Cancers: For.

Salami, Simpa S.

Affiliation

Salami SS; University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, Michigan Medicine, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. Electronic address: simpa@med.umich.edu.

Eur Urol Focus ; 8(3): 637-638, 2022 05.

Article in En | MEDLINE | ID: mdl-35817702

Subject(s)

Standard of Care; Urologic Neoplasms; Genomics; Humans; Urologic Neoplasms/genetics; Urologic Neoplasms/therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Standard of Care Limits: Humans Language: En Journal: Eur Urol Focus Year: 2022 Document type: Article Country of publication: Netherlands

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Standard of Care Limits: Humans Language: En Journal: Eur Urol Focus Year: 2022 Document type: Article Country of publication: Netherlands